Molecular Imaging and Radionuclide Therapy

Scope & Guideline

Connecting scholars to the forefront of radionuclide therapy.

Introduction

Immerse yourself in the scholarly insights of Molecular Imaging and Radionuclide Therapy with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN2146-1414
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2017 to 2024
AbbreviationMOL IMAGING RADIONUC / Mol. Imaging Radionucl. Ther.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The journal 'Molecular Imaging and Radionuclide Therapy' is dedicated to advancing the field of molecular imaging and therapy through innovative research that bridges nuclear medicine, radiology, and oncology. It emphasizes the importance of imaging techniques for diagnosis, treatment planning, and monitoring therapeutic responses in various malignancies and other diseases.
  1. Molecular Imaging Techniques:
    Focuses on the development and application of advanced imaging modalities, such as PET, SPECT, and CT, to visualize biological processes at the molecular and cellular levels.
  2. Radionuclide Therapy:
    Explores the therapeutic applications of radionuclides in treating various cancers, including the mechanisms of action, efficacy, and safety profiles of different radiopharmaceuticals.
  3. Diagnosis and Treatment Monitoring:
    Aims to improve diagnostic accuracy and treatment outcomes through imaging techniques that allow for the evaluation of treatment responses and the identification of disease recurrence.
  4. Clinical Applications in Oncology:
    Highlights the role of molecular imaging in oncology, particularly in the detection, characterization, and staging of tumors, as well as in personalized treatment approaches.
  5. Interdisciplinary Research:
    Encourages collaboration between researchers, clinicians, and industry to foster innovations in imaging and therapy, combining insights from nuclear medicine, radiology, and pathology.
The landscape of research in 'Molecular Imaging and Radionuclide Therapy' is evolving, with several emerging themes reflecting current trends in the field. These themes indicate areas of heightened interest and potential growth.
  1. Novel Radiopharmaceuticals:
    A growing body of research is focusing on the development and clinical application of novel radiopharmaceuticals, particularly those targeting specific molecular markers in cancers.
  2. Theranostics:
    The integration of therapeutic and diagnostic approaches, known as theranostics, is increasingly prevalent, allowing for personalized treatment strategies based on imaging findings.
  3. Artificial Intelligence in Imaging:
    The application of artificial intelligence and machine learning techniques for image analysis and interpretation is emerging as a significant trend, enhancing diagnostic accuracy and workflow efficiency.
  4. Immuno-PET Imaging:
    Research on immuno-PET, which combines immunotherapy with PET imaging to monitor treatment response, is gaining traction as a promising area for personalized cancer management.
  5. Radiomics and Texture Analysis:
    The use of radiomics to extract quantitative features from imaging data for predicting treatment outcomes and tumor characteristics is increasingly popular, reflecting the trend towards data-driven approaches in oncology.

Declining or Waning

While the journal maintains a strong focus on cutting-edge research, certain themes have seen a decline in prominence over recent years. This section identifies these waning scopes, reflecting shifts in research interests and advancements in technology.
  1. Non-Oncological Applications:
    Research focusing on non-oncological applications of molecular imaging and radionuclide therapy has decreased, as the field has increasingly concentrated on oncology-related studies.
  2. Older Imaging Techniques:
    There is a noticeable decline in publications centered around older imaging techniques that have been largely supplanted by more advanced methodologies, such as PET/CT and hybrid imaging.
  3. Basic Science Studies:
    The journal has shifted towards more clinically oriented research, resulting in fewer publications that focus solely on the basic science aspects of imaging and therapy.
  4. Traditional Radiopharmaceuticals:
    Research on traditional radiopharmaceuticals that do not incorporate newer imaging technologies or innovative therapeutic approaches is becoming less frequent.

Similar Journals

Hong Kong Journal of Radiology

Fostering Excellence in Radiology and Imaging Studies
Publisher: HONG KONG ACAD MEDICINE PRESSISSN: 2223-6619Frequency: 4 issues/year

Hong Kong Journal of Radiology, an esteemed publication of the Hong Kong Academy of Medicine Press, serves as a vital platform for disseminating innovative research in the field of radiology, nuclear medicine, and imaging. Established in 2011 and operating under an Open Access model since 2018, this journal not only promotes the sharing of knowledge but also enhances global accessibility to cutting-edge studies. With its ISSN 2223-6619 and E-ISSN 2307-4620, the journal strives to engage a diverse audience ranging from experienced professionals to aspiring scholars in the medical imaging domain. Despite its current ranking in the Q4 quartile of the Scopus category for radiology, the journal is committed to improving its standing by featuring high-quality research that addresses pressing issues in the field. The journal's convergence from 2011 to 2024 reflects its ongoing dedication to fostering academic excellence and encouraging collaborative discourse among researchers and practitioners globally. Located in Hong Kong, the journal plays a significant role in shaping the future of radiology education and practice in China and beyond.

Iranian Journal of Radiology

Elevating Diagnostic Imaging with Quality Insights
Publisher: BRIEFLANDISSN: 1735-1065Frequency: 4 issues/year

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Radiology and Oncology

Transforming patient outcomes with cutting-edge imaging techniques.
Publisher: SCIENDOISSN: 1318-2099Frequency: 4 issues/year

Radiology and Oncology is a prominent open access journal that has been instrumental in advancing the fields of radiology and oncology since its inception in 1992. Published by SCIENDO in Germany, this journal aims to disseminate high-quality research articles, reviews, and case studies that address critical issues in diagnostic imaging and cancer treatment. As of 2023, it holds a commendable impact factor within the Q2 category for Radiology, Nuclear Medicine, and Imaging, and a Q3 standing in the field of Oncology—reflecting its importance in these critical areas of medicine. With a focus on promoting innovative research and interdisciplinary collaboration, Radiology and Oncology is indexed in Scopus, where it ranks #122 among 333 in its category and #187 among 404 in Oncology, showcasing its wide-reaching impact and relevance. The journal is fully open access since 2007, ensuring that vital research is accessible to the global medical community and fostering advancements in patient care strategies and therapeutic methodologies. By providing a platform for the latest developments and discoveries, Radiology and Oncology is a pivotal resource for researchers, clinicians, and students dedicated to improving outcomes in cancer care through innovative imaging techniques.

BRITISH JOURNAL OF RADIOLOGY

Transforming Clinical Insights with Cutting-Edge Research
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

Indian Journal of Radiology and Imaging

Elevating Standards in Radiology and Imaging
Publisher: THIEME MEDICAL PUBL INCISSN: 0971-3026Frequency: 4 issues/year

The Indian Journal of Radiology and Imaging, published by THIEME MEDICAL PUBL INC, is a prominent open-access journal in the field of radiology, nuclear medicine, and imaging. Since its inception in 1984, the journal has provided a platform for researchers, professionals, and students to disseminate innovative research and findings in diagnostic imaging. With a growing impact factor and categorized in the Q3 quartile according to the 2023 rankings, it ranks among the notable journals in its field, although it currently stands at Rank #244 out of 333 within Scopus, reflecting its competitive position in radiology research. The journal, accessible to a global audience since 1999, aims to advance the knowledge and practice in imaging by inviting diverse contributions, including original research articles, reviews, and case reports. Its commitment to open-access publication fosters wider dissemination and collaborative discourse, crucial for the dynamic landscape of medical imaging.

Radiology-Imaging Cancer

Exploring New Frontiers in Cancer Imaging Techniques.
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)ISSN: 2638-616XFrequency: 6 issues/year

Radiology-Imaging Cancer is a prestigious journal published by the Radiological Society of North America (RSNA), focusing on the critical intersection of radiology, oncology, and advanced imaging techniques. This journal stands out in its field with a commendable ranking in the Q2 category for Medicine (miscellaneous) and Oncology, and an impressive Q1 ranking in Radiology, Nuclear Medicine and Imaging, according to the 2023 quartiles. With an ISSN of 2638-616X, it serves as an essential platform for the dissemination of research that contributes to the understanding and improvement of cancer diagnosis and treatment. Its comprehensive scope encompasses a range of topics, from innovative imaging modalities to clinical applications in oncology, making it a valuable resource for researchers, clinicians, and students interested in the evolving field of cancer imaging. Despite being published in the United States, the journal aims for a global reach, catering to a wide audience dedicated to advancing medical science.

American Journal of Nuclear Medicine and Molecular Imaging

Transforming Medical Insights with Cutting-Edge Imaging Techniques
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

NUCLEAR MEDICINE REVIEW

Elevating Standards in Nuclear Medicine Research
Publisher: VIA MEDICAISSN: 1506-9680Frequency: 2 issues/year

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

Hellenic Journal of Nuclear Medicine

Advancing Nuclear Medicine Knowledge Globally
Publisher: HELLENIC SOC NUCLEAR MEDICINEISSN: 1108-1430Frequency: 3 issues/year

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

CANCER IMAGING

Advancing the Frontiers of Cancer Diagnostics
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.